Coronary vasomotion dysfunction after everolimus-eluting stent implantation.
Pietro GiudiceTiziana AttisanoMarco Di MaioElisabetta M BellinoMaria V PolitoCesare BaldiFrancesco VigoritoMichele R Di MuroSalvatore D TomaselloAlfredo R GalassiFederico PiscionePublished in: Interventional medicine & applied science (2014)
First generation drug-eluting stent can cause a paradoxical "in-segment" coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-eluting stents (EES).